跳至主要内容
临床试验/NCT03130842
NCT03130842已完成2 期

Comparing Efficacy of Oral Midazolam and Sublingual Alprazolam in Reducing Anxiety and Pain/Discomfort Related to Diagnostic Upper Gastrointestinal Endoscopy in Adults

Isfahan University of Medical Sciences1 个研究点 分布在 1 个国家目标入组 136 人开始时间: 2016年9月17日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
136
试验地点
1
主要终点
Discomfort assessed by patients on a 11-point numeric rating scales about 5 minutes after the procedure when patients are fully awake

研究概览

简要总结

Diagnostic upper GI endoscopy can be uncomfortable and stressful for many patients. Various methods are available for sedation during this procedure. Because of some side effects related to intravenous administration of sedatives, oral administration of these drugs is under attention. Alprazolam is a benzodiazepine which is used mainly in treatment of anxiety. Intravenous midazolam is being used by some centers for sedation during endoscopy, but the oral form can also be used with probably same efficacy. Hence, investigators compare the efficacy/safety of oral midazolam and sublingual alprazolam as for sedation during this procedure. Investigators hypothesize that sublingual alprazolam is as effective as oral midazolam in reducing anxiety and pain/discomfort related to the procedure.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Referring for upper GI endoscopy
  • Age 18 to 65 years
  • First experience of upper GI endoscopy
  • Class I or II of American Anesthesiology Association
  • Willingness to participate

排除标准

  • Severe psychiatric, neurological, cardio-vascular, or renal disorders
  • History of allergy or intolerance to benzodiazepines or lidocaine
  • History of upper GI surgery
  • Pregnancy or lactation
  • GI anomalia during endoscopy
  • Need for therapeutic procedures during endoscopy
  • Active bleeding

研究组 & 干预措施

Sublingual alprazolam

Active Comparator

干预措施: Sublingual alprazolam (Drug)

Oral midazolam

Active Comparator

干预措施: Oral midazolam (Drug)

结局指标

主要结局

Discomfort assessed by patients on a 11-point numeric rating scales about 5 minutes after the procedure when patients are fully awake

时间窗: 5 minutes after the procedure

Procedure related discomfort is assessed by patients on a 11-point numeric rating scales about 5 minutes after the procedure when patients are fully awake.

Change in anxiety

时间窗: At baseline and at 30 minutes after medication

Procedure related anxiety is assessed by patients on a 11-point numeric rating scales at baseline and then at 30 minutes after the medication.

次要结局

  • Desaturation(At baseline, 30 minutes after medication, at the beginning of procedure, and then every 5 minutes for 30 minutes.)
  • Satisfaction is assessed by patients on a 11-point numeric rating scales about 5 minutes after the procedure when patients are fully awake.(5 minutes after the procedure)
  • Tolerance is assessed by patients from no compliance (0) to excellent compliance (4) about 5 minutes after the procedure when patients are fully awake.(5 minutes after the procedure)
  • Duration of the procedure(From endoscope insertion to endoscope removal)
  • Hypotension(At baseline, 30 minutes after medication, at the beginning of procedure, and then every 5 minutes for 30 minutes.)
  • Bradycardia(At baseline, 30 minutes after medication, at the beginning of procedure, and then every 5 minutes for 30 minutes.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Elham Tabesh

Dr.

Isfahan University of Medical Sciences

研究点 (1)

Loading locations...

相似试验